Definitive Healthcare (DH) Stock Forecast & Price Target

$0.81 -0.05 (-6.06%)

Closing price 05/15/2026 04:00 PM Eastern

Extended Trading

$0.81 +0.01 (+0.63%)

As of 05/15/2026 06:37 PM Eastern

Compare

Definitive Healthcare - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 8 Analyst Ratings

Sell
3

Hold
3

Buy
2

Based on 8 Wall Street analysts who have issued ratings for Definitive Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 8 analysts, 3 have given a sell rating, 3 have given a hold rating, 1 has given a buy rating, and 1 has given a strong buy rating for DH.

Consensus Price Target

$2.77
242.45% Upside

According to the 8 analysts' twelve-month price targets for Definitive Healthcare, the average price target is $2.77. The highest price target for DH is $6.00, while the lowest price target for DH is $1.00. The average price target represents a forecasted upside of 242.45% from the current price of $0.81.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for DH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Definitive Healthcare and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DH Analyst Ratings Over Time

Type	Current Forecast 5/17/25 to 5/17/26	1 Month Ago 4/17/25 to 4/17/26	3 Months Ago 2/16/25 to 2/16/26	1 Year Ago 5/17/24 to 5/17/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)
Hold	3 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)	7 Hold rating(s)
Sell	3 Sell rating(s)	4 Sell rating(s)	3 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$2.77	$3.27	$3.94	$5.10
Forecasted Upside	242.45% Upside	217.61% Upside	147.90% Upside	55.49% Upside
Consensus Rating	Hold	Reduce	Hold	Reduce

DH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Definitive Healthcare Stock vs. The Competition

Type	Definitive Healthcare	Computer and Technology Companies	Broader Market
Consensus Rating Score	2.00	2.30	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	242.45% Upside	148.28% Upside	17.90% Upside
News Sentiment Rating	Neutral News See Recent DH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/8/2026	Robert W. Baird 3 of 5 stars		Set Target		$1.10	+16.90%
4/28/2026	Zacks Research Not Rated		Upgrade	Strong Sell ➝ Hold
3/30/2026	Barclays 3 of 5 stars	Saket Kalia 1 of 5 stars	Lower Target	Underweight	$2.75 ➝ $1.00	-9.50%
2/27/2026	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Hold	$4.00 ➝ $3.00	+142.91%
2/27/2026	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Garro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$3.00 ➝ $2.00	+65.29%
1/21/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Sell (D-)
12/18/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Hettenbach Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Underperform	$3.50	+53.51%
11/6/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
8/8/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Grossman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$5.00 ➝ $6.00	+48.48%
5/12/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$3.00 ➝ $3.40	-4.90%
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing
5/9/2025	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Larsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Neutral
1/16/2025	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Hold
8/9/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Hold	$7.00 ➝ $5.00	+27.23%
7/31/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Neutral ➝ Underweight	$7.00 ➝ $5.00	-12.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:12 PM ET.

DH Forecast - Frequently Asked Questions

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Definitive Healthcare is $2.77, with a high forecast of $6.00 and a low forecast of $1.00.

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There are currently 3 sell ratings, 3 hold ratings, 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares.

According to analysts, Definitive Healthcare's stock has a predicted upside of 242.45% based on their 12-month stock forecasts.

Over the previous 90 days, Definitive Healthcare's stock had 1 upgrade and 1 downgrade by analysts.

Definitive Healthcare has been rated by research analysts at Barclays, Canaccord Genuity Group, Robert W. Baird, Stephens, and Zacks Research in the past 90 days.

Analysts like Definitive Healthcare less than other "computer and technology" companies. The consensus rating score for Definitive Healthcare is 2.00 while the average consensus rating score for "computer and technology" companies is 2.30. Learn more on how DH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Definitive Healthcare Recommendations

This page (NASDAQ:DH) was last updated on 5/17/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Definitive Healthcare (DH) Stock Forecast & Price Target

Definitive Healthcare - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

DH Analyst Ratings Over Time

DH Analyst Recommendations By Month

DH Price Targets by Month

Definitive Healthcare Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

DH Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Definitive Healthcare Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Definitive Healthcare (DH) Stock Forecast & Price Target

Definitive Healthcare - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

DH Analyst Ratings Over Time

DH Analyst Recommendations By Month

DH Price Targets by Month

Definitive Healthcare Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

DH Forecast - Frequently Asked Questions

What is Definitive Healthcare's forecast for 2026?

Should I buy or sell Definitive Healthcare stock right now?

Does Definitive Healthcare's stock price have much upside?

Has Definitive Healthcare been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Definitive Healthcare?

Do Wall Street analysts like Definitive Healthcare more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Definitive Healthcare Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools